CDC42EP3 Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9UKI2 |
---|---|
Other Accession | NP_006440 |
Clone Names | 91023157 |
Gene ID | 10602 |
---|---|
Other Names | Cdc42 effector protein 3, Binder of Rho GTPases 2, MSE55-related Cdc42-binding protein, CDC42EP3, BORG2, CEP3 |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP8775a was selected from the N-term region of human CDC42EP3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | CDC42EP3 |
---|---|
Synonyms | BORG2, CEP3 |
Function | Probably involved in the organization of the actin cytoskeleton. May act downstream of CDC42 to induce actin filament assembly leading to cell shape changes. Induces pseudopodia formation in fibroblasts. |
Cellular Location | Endomembrane system; Peripheral membrane protein. Cytoplasm, cytoskeleton |
Tissue Location | Highly expressed in the heart and weakly in the brain. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
CDC42EP3 is probably involved in the organization of the actin cytoskeleton. May act downstream of CDC42 to induce actin filament assembly leading to cell shape changes. It induces pseudopodia formation in fibroblasts.
References
Simpson,J.C., et.al., EMBO Rep. 1 (3), 287-292 (2000)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.